Final Up to date:September 10, 2025, 07:00 IST
The CDSCO has invited public feedback on the proposal, marking a major step in the direction of enhancing accessibility for the visually impaired inhabitants
To assist simpler entry to treatment for visually impaired individuals, the rule of thumb on extra labelling in Braille is proposed to be applied ‘initially voluntarily’ for medicine provided in mono carton pack measurement—probably the most frequent packaging codecs within the pharma, FMCG, and cosmetics industries. Representational picture
Drug merchandise seemingly for use by a bigger visually impaired affected person group, comparable to sure “eye drop preparations”, may quickly carry Braille labels, QR codes linked to voice help, or Braille playing cards of their packaging. The Central Medicine Commonplace Management Organisation (CDSCO) has invited public feedback on the proposal recommended by the apex panel, marking a major step in the direction of enhancing accessibility for the visually impaired inhabitants.
The transfer, earlier reported by News18, follows long-standing issues that such sufferers battle to establish medicines and expiry dates on strips, forcing them to depend upon others for secure utilization. To assist simpler entry to treatment for visually impaired individuals, the rule of thumb on extra labelling in Braille is proposed to be applied “initially voluntarily” for medicine provided in mono carton pack measurement—probably the most frequent packaging codecs within the pharma, FMCG, and cosmetics industries.
What order says
“This directorate has acquired representations concerning issues confronted by blind or visually impaired folks in studying the strips of medicines. These particular folks face problem to know the identify/expiry of the medicines and depend upon others; subsequently, they requested for a provision underneath the Medicine and Cosmetics Act and Guidelines to label the medicine with Braille inscriptions,” stated the order issued by Drug Controller Basic of India, Rajeev Singh Raghuvanshi, on September 9.
The regulator is now inviting public feedback on the proposal, which was closely mentioned by the apex panel, the Medicine Consultative Committee, in 2020 and 2025. The panel proposed that individual consideration ought to be given to medicinal merchandise seemingly for use by a excessive visually impaired goal inhabitants, comparable to sure “eye drop preparations”.
“Such Braille labels usually are not relevant for the merchandise disbursed or given underneath the supervision of a well being care skilled, for e.g. injectable, vaccine and so on,” stated Raghuvanshi’s order, quoting the proposals recommended by the Medicine Consultative Committee in 2020.
Other than the DCC’s proposals, the DCGI has provided extra choices for public consideration, together with the usage of QR codes linked with voice help and the inclusion of Braille playing cards in secondary packaging of medicines containing greater than 10 models.
Proposal for alleviating drug decisions for blind, partially blind folks
In accordance with the DCC suggestions, the Braille paintings, as developed by the producer, ought to be validated by the nodal company, just like the Nationwide Institute for the Empowerment of Individuals with Mental Disabilities (NIEPID), by way of the Braille Council of India (BCI) or some other company really useful by the NIEPID.
“Braille isn’t merely embossed dots—it follows a strict code. Any mistake in spacing, dot placement, or transcription can fully change the which means. For medicines, errors may very well be harmful, comparable to a improper drug identify or a improper power. Validation ensures the Braille printed is right and readable by skilled customers,” stated a senior authorities official, explaining the rationale behind the suggestions, whereas requesting anonymity as he was not authorised to talk to the media formally.
Citing the European Fee guideline of the Readability of the Labelling and Package deal Leaflet of Medicinal Merchandise for Human Use, the order issued by DCGI stated, “The sort measurement ought to be as massive as potential to help readers.”
It additionally added that the advertising and marketing authorisation holder—the one who will maintain rights to market the drug or medicinal product—could be certain that the package deal info leaflet is made accessible on request from sufferers/stakeholders in codecs acceptable for the blind and the partially sighted.
“On a drugs pack, solely restricted info (normally the drug identify and power) will be embossed in Braille due to house constraints. Sufferers nonetheless want entry to the detailed package deal leaflet—dosage directions, negative effects, storage situations, warnings, and so on—which is much too lengthy to slot in Braille on a carton,” the officer stated whereas including that offering the leaflet in accessible codecs (Braille booklet, massive print, audio, or digital screen-reader suitable variations) ensures they’ve the identical stage of drug security info.
The panel has additionally proposed the “issuance of an advisory by the competent authority for the retailers underneath their jurisdiction to information such inhabitants verbally in regards to the dosage kind, identify of the medicines, indication and makes use of, together with some other info, like expiry date, and so on, that may be routinely adopted up by the enforcement officers.”
Nevertheless, the trade officers News18 spoke with had been sceptical about whether or not each drugmaker would spend money on it. “Because the transfer isn’t necessary, drugmakers could also be reluctant to undertake it given the added prices and design modifications, although some bigger companies may nonetheless view it as a step towards affected person belief and company accountability,” an trade veteran stated.
Himani Chandna, Affiliate Editor at CNN News18, specialises in healthcare and prescribed drugs. With firsthand insights into India’s COVID-19 battle, she brings a seasoned perspective.
She is especially move…Learn Extra
Himani Chandna, Affiliate Editor at CNN News18, specialises in healthcare and prescribed drugs. With firsthand insights into India’s COVID-19 battle, she brings a seasoned perspective.
She is especially move… Learn Extra
September 10, 2025, 07:00 IST
Learn Extra
